Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 1/2012

01.01.2012 | Review

Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality

verfasst von: T. Welte

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Morbidity and mortality in patients with moderate to severe community-acquired pneumonia (CAP) is a global problem, and CAP is a leading cause of death due to infectious diseases. Prompt initiation of expanded-spectrum antimicrobials is essential for the prevention of unnecessary mortality and complications in patients, particularly in the elderly and other at-risk populations, and the treatment decisions made by practitioners have important implications for healthcare systems when hospitalization is required. Empirical antimicrobial treatment and the appropriate management of CAP patients will initially require the proper assessment of severity and patient risk for increased mortality, as well as risk factors for difficult-to-treat bacteria. This review will examine risk factors and scoring systems that may be predictive of moderate to severe CAP, which is often linked to increased risk of mortality. Understanding and recognizing potential risk factors will allow practitioners to proactively identify patients at the highest risk for severe illness or complications, thereby, guiding site-of-care decisions, as well as the choices for empiric antibiotic regimens. The decision to hospitalize a patient with CAP should include not only a clinical perspective and laboratory and radiographic findings, but also at least one objective tool of risk assessment, all in combination with sound clinical judgment.
Literatur
1.
Zurück zum Zitat Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R (1998) The cost of treating community-acquired pneumonia. Clin Ther 20(4):820–837PubMed Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R (1998) The cost of treating community-acquired pneumonia. Clin Ther 20(4):820–837PubMed
2.
Zurück zum Zitat Schnoor M, Hedicke J, Dalhoff K, Raspe H, Schäfer T (2007) Approaches to estimate the population-based incidence of community acquired pneumonia. J Infect 55(3):233–239PubMed Schnoor M, Hedicke J, Dalhoff K, Raspe H, Schäfer T (2007) Approaches to estimate the population-based incidence of community acquired pneumonia. J Infect 55(3):233–239PubMed
3.
Zurück zum Zitat Viegi G, Pistelli R, Cazzola M, Falcone F, Cerveri I, Rossi A, Ugo Di Maria G (2006) Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy. Respir Med 100(1):46–55PubMed Viegi G, Pistelli R, Cazzola M, Falcone F, Cerveri I, Rossi A, Ugo Di Maria G (2006) Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy. Respir Med 100(1):46–55PubMed
4.
Zurück zum Zitat Dias J, Correia AM, Queirós L (2007) Community-acquired pneumonia and influenza hospitalisations in northern Portugal, 2000–2005. Euro Surveill 12(7):E13–E14PubMed Dias J, Correia AM, Queirós L (2007) Community-acquired pneumonia and influenza hospitalisations in northern Portugal, 2000–2005. Euro Surveill 12(7):E13–E14PubMed
5.
Zurück zum Zitat Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN (1996) Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 275(2):134–141PubMed Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN (1996) Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 275(2):134–141PubMed
6.
Zurück zum Zitat Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 31(2):347–382PubMed Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 31(2):347–382PubMed
7.
Zurück zum Zitat Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336(4):243–250PubMed Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336(4):243–250PubMed
8.
Zurück zum Zitat Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, Berkelman RL (1996) Trends in infectious diseases mortality in the United States. JAMA 275(3):189–193PubMed Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, Berkelman RL (1996) Trends in infectious diseases mortality in the United States. JAMA 275(3):189–193PubMed
9.
Zurück zum Zitat Welte T, Marre R, Suttorp N (2006) What is new in the treatment of community-acquired pneumonia? Med Klin (Munich) 101(4):313–320 Welte T, Marre R, Suttorp N (2006) What is new in the treatment of community-acquired pneumonia? Med Klin (Munich) 101(4):313–320
10.
Zurück zum Zitat Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, Linde-Zwirble WT, Angus DC (2003) Pneumonia: still the old man’s friend? Arch Intern Med 163(3):317–323PubMed Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, Linde-Zwirble WT, Angus DC (2003) Pneumonia: still the old man’s friend? Arch Intern Med 163(3):317–323PubMed
11.
Zurück zum Zitat Rosón B, Carratalà J, Fernández-Sabé N, Tubau F, Manresa F, Gudiol F (2004) Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 164(5):502–508PubMed Rosón B, Carratalà J, Fernández-Sabé N, Tubau F, Manresa F, Gudiol F (2004) Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 164(5):502–508PubMed
12.
Zurück zum Zitat Monge V, San-Martín VM, González A (2001) The burden of community-acquired pneumonia in Spain. Eur J Public Health 11(4):362–364PubMed Monge V, San-Martín VM, González A (2001) The burden of community-acquired pneumonia in Spain. Eur J Public Health 11(4):362–364PubMed
13.
Zurück zum Zitat Grassi V, Romanelli G (2006) Pneumonia: state-of-art and perspectives. Recenti Prog Med 97(12):697–703PubMed Grassi V, Romanelli G (2006) Pneumonia: state-of-art and perspectives. Recenti Prog Med 97(12):697–703PubMed
14.
Zurück zum Zitat Welte T (2007) Treatment of community acquired pneumonia. Internist (Berl) 48(5):476, 478–480, 482–484 passim Welte T (2007) Treatment of community acquired pneumonia. Internist (Berl) 48(5):476, 478–480, 482–484 passim
15.
Zurück zum Zitat Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37(11):1405–1433PubMed Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37(11):1405–1433PubMed
16.
Zurück zum Zitat Lode HM (2007) Managing community-acquired pneumonia: a European perspective. Respir Med 101(9):1864–1873PubMed Lode HM (2007) Managing community-acquired pneumonia: a European perspective. Respir Med 101(9):1864–1873PubMed
17.
Zurück zum Zitat Farr BM, Bartlett CL, Wadsworth J, Miller DL (2000) Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group. Respir Med 94(10):954–963PubMed Farr BM, Bartlett CL, Wadsworth J, Miller DL (2000) Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group. Respir Med 94(10):954–963PubMed
18.
Zurück zum Zitat Kohlhammer Y, Schwartz M, Raspe H, Schäfer T (2005) Risk factors for community acquired pneumonia (CAP). A systematic review. Dtsch Med Wochenschr 130(8):381–386PubMed Kohlhammer Y, Schwartz M, Raspe H, Schäfer T (2005) Risk factors for community acquired pneumonia (CAP). A systematic review. Dtsch Med Wochenschr 130(8):381–386PubMed
19.
Zurück zum Zitat Gutiérrez F, Masiá M, Mirete C, Soldán B, Rodríguez JC, Padilla S, Hernández I, Royo G, Martin-Hidalgo A (2006) The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 53(3):166–174PubMed Gutiérrez F, Masiá M, Mirete C, Soldán B, Rodríguez JC, Padilla S, Hernández I, Royo G, Martin-Hidalgo A (2006) The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 53(3):166–174PubMed
20.
Zurück zum Zitat Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT (2002) Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 165(6):766–772PubMed Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT (2002) Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 165(6):766–772PubMed
21.
Zurück zum Zitat Riquelme R, Torres A, El-Ebiary M, de la Bellacasa JP, Estruch R, Mensa J, Fernández-Solá J, Hernández C, Rodriguez-Roisin R (1996) Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 154(5):1450–1455PubMed Riquelme R, Torres A, El-Ebiary M, de la Bellacasa JP, Estruch R, Mensa J, Fernández-Solá J, Hernández C, Rodriguez-Roisin R (1996) Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 154(5):1450–1455PubMed
22.
Zurück zum Zitat From S, Targowski T (2002) The risk factors of death in community-acquired pneumonia. Pol Merkur Lekarski 12(72):455–457PubMed From S, Targowski T (2002) The risk factors of death in community-acquired pneumonia. Pol Merkur Lekarski 12(72):455–457PubMed
23.
Zurück zum Zitat Cabré M, Serra-Prat M, Bolíbar I, Pallarés R (2006) Prognostic factors of community acquired pneumonia in very old patients. Med Clin (Barc) 127(6):201–205 Cabré M, Serra-Prat M, Bolíbar I, Pallarés R (2006) Prognostic factors of community acquired pneumonia in very old patients. Med Clin (Barc) 127(6):201–205
24.
Zurück zum Zitat Niederman MS, Ahmed QA (2003) Community-acquired pneumonia in elderly patients. Clin Geriatr Med 19(1):101–120PubMed Niederman MS, Ahmed QA (2003) Community-acquired pneumonia in elderly patients. Clin Geriatr Med 19(1):101–120PubMed
25.
Zurück zum Zitat Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH (2007) Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 51(10):3568–3573PubMed Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH (2007) Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 51(10):3568–3573PubMed
26.
Zurück zum Zitat Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K (2008) Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 32(1):139–146PubMed Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K (2008) Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 32(1):139–146PubMed
27.
Zurück zum Zitat Carratalà J, Mykietiuk A, Fernández-Sabé N, Suárez C, Dorca J, Verdaguer R, Manresa F, Gudiol F (2007) Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 167(13):1393–1399PubMed Carratalà J, Mykietiuk A, Fernández-Sabé N, Suárez C, Dorca J, Verdaguer R, Manresa F, Gudiol F (2007) Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 167(13):1393–1399PubMed
28.
Zurück zum Zitat Ortqvist A (1990) Prognosis in community-acquired pneumonia requiring treatment in hospital. Importance of predisposing and complicating factors, and of diagnostic procedures. Scand J Infect Dis Suppl 65:1–62PubMed Ortqvist A (1990) Prognosis in community-acquired pneumonia requiring treatment in hospital. Importance of predisposing and complicating factors, and of diagnostic procedures. Scand J Infect Dis Suppl 65:1–62PubMed
29.
Zurück zum Zitat Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A (2008) A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest 133:610–617PubMed Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A (2008) A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest 133:610–617PubMed
30.
Zurück zum Zitat Angele MK, Frantz MC, Chaudry IH (2006) Gender and sex hormones influence the response to trauma and sepsis: potential therapeutic approaches. Clinics (Sao Paulo) 61(5):479–488 Angele MK, Frantz MC, Chaudry IH (2006) Gender and sex hormones influence the response to trauma and sepsis: potential therapeutic approaches. Clinics (Sao Paulo) 61(5):479–488
31.
Zurück zum Zitat Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH (1997) Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25(1):106–110PubMed Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH (1997) Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25(1):106–110PubMed
32.
Zurück zum Zitat Schröder J, Kahlke V, Book M, Stüber F (2000) Gender differences in sepsis: genetically determined? Shock 14(3):307–310PubMed Schröder J, Kahlke V, Book M, Stüber F (2000) Gender differences in sepsis: genetically determined? Shock 14(3):307–310PubMed
33.
Zurück zum Zitat Mortensen EM, Cornell J, Whittle J (2004) Racial variations in processes of care for patients with community-acquired pneumonia. BMC Health Serv Res 4(1):20PubMed Mortensen EM, Cornell J, Whittle J (2004) Racial variations in processes of care for patients with community-acquired pneumonia. BMC Health Serv Res 4(1):20PubMed
34.
Zurück zum Zitat Oliver MN, Stukenborg GJ, Wagner DP, Harrell FE Jr, Kilbridge KL, Lyman JA, Einbinder J, Connors AF Jr (2004) Comorbid disease and the effect of race and ethnicity on in-hospital mortality from aspiration pneumonia. J Natl Med Assoc 96(11):1462–1469PubMed Oliver MN, Stukenborg GJ, Wagner DP, Harrell FE Jr, Kilbridge KL, Lyman JA, Einbinder J, Connors AF Jr (2004) Comorbid disease and the effect of race and ethnicity on in-hospital mortality from aspiration pneumonia. J Natl Med Assoc 96(11):1462–1469PubMed
35.
Zurück zum Zitat Carbon C (2001) Optimal treatment strategies for community-acquired pneumonia: high-risk patients (geriatric and with comorbidity). Chemotherapy 47(Suppl 4):19–25, discussion 26–27PubMed Carbon C (2001) Optimal treatment strategies for community-acquired pneumonia: high-risk patients (geriatric and with comorbidity). Chemotherapy 47(Suppl 4):19–25, discussion 26–27PubMed
36.
Zurück zum Zitat O’Meara ES, White M, Siscovick DS, Lyles MF, Kuller LH (2005) Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival. J Am Geriatr Soc 53(7):1108–1116PubMed O’Meara ES, White M, Siscovick DS, Lyles MF, Kuller LH (2005) Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival. J Am Geriatr Soc 53(7):1108–1116PubMed
37.
Zurück zum Zitat Almirall J, Bolíbar I, Balanzó X, González CA (1999) Risk factors for community-acquired pneumonia in adults: a population-based case–control study. Eur Respir J 13(2):349–355PubMed Almirall J, Bolíbar I, Balanzó X, González CA (1999) Risk factors for community-acquired pneumonia in adults: a population-based case–control study. Eur Respir J 13(2):349–355PubMed
38.
Zurück zum Zitat Almirall J, Bolíbar I, Serra-Prat M, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A (2008) New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J 31:1274–1284PubMed Almirall J, Bolíbar I, Serra-Prat M, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A (2008) New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J 31:1274–1284PubMed
39.
Zurück zum Zitat Schnoor M, Klante T, Beckmann M, Robra BP, Welte T, Raspe H, Schäfer T (2007) Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect 135(8):1389–1397PubMed Schnoor M, Klante T, Beckmann M, Robra BP, Welte T, Raspe H, Schäfer T (2007) Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect 135(8):1389–1397PubMed
40.
Zurück zum Zitat Marrie TJ, Shariatzadeh MR (2007) Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore) 86(2):103–111 Marrie TJ, Shariatzadeh MR (2007) Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore) 86(2):103–111
41.
Zurück zum Zitat Pifarre R, Falguera M, Vicente-de-Vera C, Nogues A (2007) Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med 101(10):2139–2144PubMed Pifarre R, Falguera M, Vicente-de-Vera C, Nogues A (2007) Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med 101(10):2139–2144PubMed
42.
Zurück zum Zitat Menéndez R, Torres A, Zalacaín R, Aspa J, Martín Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Rodríguez de Castro F, Blanquer J, Pérez D, Puzo C, Sánchez Gascón F, Gallardo J, Alvarez C, Molinos L (2004) Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 59(11):960–965PubMed Menéndez R, Torres A, Zalacaín R, Aspa J, Martín Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Rodríguez de Castro F, Blanquer J, Pérez D, Puzo C, Sánchez Gascón F, Gallardo J, Alvarez C, Molinos L (2004) Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 59(11):960–965PubMed
43.
Zurück zum Zitat Restrepo MI, Mortensen EM, Pugh JA, Anzueto A (2006) COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 28(2):346–351PubMed Restrepo MI, Mortensen EM, Pugh JA, Anzueto A (2006) COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 28(2):346–351PubMed
44.
Zurück zum Zitat Rello J, Rodriguez A, Torres A, Roig J, Sole-Violan J, Garnacho-Montero J, de la Torre MV, Sirvent JM, Bodi M (2006) Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 27(6):1210–1216PubMed Rello J, Rodriguez A, Torres A, Roig J, Sole-Violan J, Garnacho-Montero J, de la Torre MV, Sirvent JM, Bodi M (2006) Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 27(6):1210–1216PubMed
45.
Zurück zum Zitat Fujiki R, Kawayama T, Ueyama T, Ichiki M, Aizawa H (2007) The risk factors for mortality of community-acquired pneumonia in Japan. J Infect Chemother 13(3):157–165PubMed Fujiki R, Kawayama T, Ueyama T, Ichiki M, Aizawa H (2007) The risk factors for mortality of community-acquired pneumonia in Japan. J Infect Chemother 13(3):157–165PubMed
46.
Zurück zum Zitat Klare B, Kubini R, Ewig S (2002) Risk factors for pneumonia in patients with cardiovascular diseases. Pneumologie 56(12):781–788PubMed Klare B, Kubini R, Ewig S (2002) Risk factors for pneumonia in patients with cardiovascular diseases. Pneumologie 56(12):781–788PubMed
47.
Zurück zum Zitat Ruiz M, Ewig S, Torres A, Arancibia F, Marco F, Mensa J, Sanchez M, Martinez JA (1999) Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med 160(3):923–929PubMed Ruiz M, Ewig S, Torres A, Arancibia F, Marco F, Mensa J, Sanchez M, Martinez JA (1999) Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med 160(3):923–929PubMed
48.
Zurück zum Zitat Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, Génin R, Yvin JL (2004) Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 24(5):779–785PubMed Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, Génin R, Yvin JL (2004) Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 24(5):779–785PubMed
49.
Zurück zum Zitat Fernández-Solá J, Junqué A, Estruch R, Monforte R, Torres A, Urbano-Márquez A (1995) High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 155(15):1649–1654PubMed Fernández-Solá J, Junqué A, Estruch R, Monforte R, Torres A, Urbano-Márquez A (1995) High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 155(15):1649–1654PubMed
50.
Zurück zum Zitat Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A (2005) Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 128(5):3233–3239PubMed Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A (2005) Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 128(5):3233–3239PubMed
51.
Zurück zum Zitat Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT (2007) Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care 30(9):2251–2257PubMed Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT (2007) Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care 30(9):2251–2257PubMed
52.
Zurück zum Zitat Genné D, Sommer R, Kaiser L, Saaïdia A, Pasche A, Unger PF, Lew D (2006) Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 25(3):159–166PubMed Genné D, Sommer R, Kaiser L, Saaïdia A, Pasche A, Unger PF, Lew D (2006) Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 25(3):159–166PubMed
53.
Zurück zum Zitat van Eeden SF, Coetzee AR, Joubert JR (1988) Community-acquired pneumonia—factors influencing intensive care admission. S Afr Med J 73(2):77–81PubMed van Eeden SF, Coetzee AR, Joubert JR (1988) Community-acquired pneumonia—factors influencing intensive care admission. S Afr Med J 73(2):77–81PubMed
54.
Zurück zum Zitat Luna CM, Famiglietti A, Absi R, Videla AJ, Nogueira FJ, Fuenzalida AD, Gené RJ (2000) Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 118(5):1344–1354PubMed Luna CM, Famiglietti A, Absi R, Videla AJ, Nogueira FJ, Fuenzalida AD, Gené RJ (2000) Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 118(5):1344–1354PubMed
55.
Zurück zum Zitat Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ (2008) Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis 46(4):550–556PubMed Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ (2008) Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis 46(4):550–556PubMed
56.
Zurück zum Zitat Peach H, Barnett N (2001) Does smoking contribute to community acquired pneumonia? Aust Fam Physician 30(1):10PubMed Peach H, Barnett N (2001) Does smoking contribute to community acquired pneumonia? Aust Fam Physician 30(1):10PubMed
57.
Zurück zum Zitat Almirall J, González CA, Balanzó X, Bolíbar I (1999) Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest 116(2):375–379PubMed Almirall J, González CA, Balanzó X, Bolíbar I (1999) Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest 116(2):375–379PubMed
58.
Zurück zum Zitat Inoue Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Tamakoshi A (2007) Risk and protective factors related to mortality from pneumonia among middleaged and elderly community residents: the JACC Study. J Epidemiol 17(6):194–202PubMed Inoue Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Tamakoshi A (2007) Risk and protective factors related to mortality from pneumonia among middleaged and elderly community residents: the JACC Study. J Epidemiol 17(6):194–202PubMed
59.
Zurück zum Zitat Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72PubMed Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72PubMed
60.
Zurück zum Zitat Ewig S, de Roux A, Bauer T, García E, Mensa J, Niederman M, Torres A (2004) Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 59(5):421–427PubMed Ewig S, de Roux A, Bauer T, García E, Mensa J, Niederman M, Torres A (2004) Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 59(5):421–427PubMed
61.
Zurück zum Zitat España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM (2006) Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 174(11):1249–1256PubMed España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM (2006) Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 174(11):1249–1256PubMed
62.
Zurück zum Zitat Gil DR, Undurraga PA, Saldías PF, Jiménez PP, Barros MM (2006) Prognostic factors and outcome of community-acquired pneumonia in hospitalized adult patients. Rev Med Chil 134(11):1357–1366 Gil DR, Undurraga PA, Saldías PF, Jiménez PP, Barros MM (2006) Prognostic factors and outcome of community-acquired pneumonia in hospitalized adult patients. Rev Med Chil 134(11):1357–1366
63.
Zurück zum Zitat [No authors listed] (1987) Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Q J Med 62(239):195–220 [No authors listed] (1987) Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Q J Med 62(239):195–220
64.
Zurück zum Zitat Raz R, Dyachenko P, Levy Y, Flatau E, Reichman N (2003) A predictive model for the management of community-acquired pneumonia. Infection 31(1):3–8PubMed Raz R, Dyachenko P, Levy Y, Flatau E, Reichman N (2003) A predictive model for the management of community-acquired pneumonia. Infection 31(1):3–8PubMed
65.
Zurück zum Zitat Gillet Y, Vanhems P, Lina G, Bes M, Vandenesch F, Floret D, Etienne J (2007) Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton–Valentine leukocidin. Clin Infect Dis 45(3):315–321PubMed Gillet Y, Vanhems P, Lina G, Bes M, Vandenesch F, Floret D, Etienne J (2007) Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton–Valentine leukocidin. Clin Infect Dis 45(3):315–321PubMed
66.
Zurück zum Zitat Hedlund JU, Ortqvist AB, Kalin ME, Granath F (1993) Factors of importance for the long term prognosis after hospital treated pneumonia. Thorax 48(8):785–789PubMed Hedlund JU, Ortqvist AB, Kalin ME, Granath F (1993) Factors of importance for the long term prognosis after hospital treated pneumonia. Thorax 48(8):785–789PubMed
67.
Zurück zum Zitat Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58(5):377–382PubMed Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58(5):377–382PubMed
68.
Zurück zum Zitat Chalmers JD, Singanayagam A, Murray MP, Hill AT (2008) Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 121(11):1002–1007PubMed Chalmers JD, Singanayagam A, Murray MP, Hill AT (2008) Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 121(11):1002–1007PubMed
69.
Zurück zum Zitat Ernst P, Gonzalez AV, Brassard P, Suissa S (2007) Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 176(2):162–166PubMed Ernst P, Gonzalez AV, Brassard P, Suissa S (2007) Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 176(2):162–166PubMed
70.
Zurück zum Zitat Woodhead M (2003) Assessment of illness severity in community acquired pneumonia: a useful new prediction tool? Thorax 58(5):371–372PubMed Woodhead M (2003) Assessment of illness severity in community acquired pneumonia: a useful new prediction tool? Thorax 58(5):371–372PubMed
71.
Zurück zum Zitat Capelastegui A, España PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, Bilbao A (2006) Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 27(1):151–157PubMed Capelastegui A, España PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, Bilbao A (2006) Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 27(1):151–157PubMed
72.
Zurück zum Zitat Bauer TT, Ewig S, Marre R, Suttorp N, Welte T (2006) CRB-65 predicts death from community-acquired pneumonia. J Intern Med 260(1):93–101PubMed Bauer TT, Ewig S, Marre R, Suttorp N, Welte T (2006) CRB-65 predicts death from community-acquired pneumonia. J Intern Med 260(1):93–101PubMed
73.
Zurück zum Zitat Ewig S, Welte T (2008) CRB-65 for the assessment of pneumonia severity: who could ask for more? Thorax 63(8):665–666PubMed Ewig S, Welte T (2008) CRB-65 for the assessment of pneumonia severity: who could ask for more? Thorax 63(8):665–666PubMed
74.
Zurück zum Zitat Chalmers JD, Singanayagam A, Hill AT (2008) Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia. Thorax 63(8):698–702PubMed Chalmers JD, Singanayagam A, Hill AT (2008) Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia. Thorax 63(8):698–702PubMed
75.
Zurück zum Zitat Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French G, Lewis D (2008) Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 61(5):976–994PubMed Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French G, Lewis D (2008) Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 61(5):976–994PubMed
76.
Zurück zum Zitat Niederman MS, Bass JB Jr, Campbell GD, Fein AM, Grossman RF, Mandell LA, Marrie TJ, Sarosi GA, Torres A, Yu VL (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 148(5):1418–1426PubMed Niederman MS, Bass JB Jr, Campbell GD, Fein AM, Grossman RF, Mandell LA, Marrie TJ, Sarosi GA, Torres A, Yu VL (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 148(5):1418–1426PubMed
77.
Zurück zum Zitat Niederman MS (2001) Guidelines for the management of community-acquired pneumonia. Current recommendations and antibiotic selection issues. Med Clin North Am 85(6):1493–1509PubMed Niederman MS (2001) Guidelines for the management of community-acquired pneumonia. Current recommendations and antibiotic selection issues. Med Clin North Am 85(6):1493–1509PubMed
78.
Zurück zum Zitat Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M, Grayson ML (2008) SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 47(3):375–384PubMed Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M, Grayson ML (2008) SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 47(3):375–384PubMed
79.
Zurück zum Zitat Chalmers JD, Singanayagam A, Hill AT (2008) Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia. Clin Infect Dis 47(12):1571–1574PubMed Chalmers JD, Singanayagam A, Hill AT (2008) Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia. Clin Infect Dis 47(12):1571–1574PubMed
80.
Zurück zum Zitat Yandiola PP, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, Zalacain R, Menendez R, Torres A (2009) Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest 135(6):1572–1579PubMed Yandiola PP, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, Zalacain R, Menendez R, Torres A (2009) Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest 135(6):1572–1579PubMed
81.
Zurück zum Zitat Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T (2007) Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 33(12):2069–2078PubMed Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T (2007) Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 33(12):2069–2078PubMed
82.
Zurück zum Zitat Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T (2008) Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 31(2):349–355PubMed Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T (2008) Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 31(2):349–355PubMed
83.
Zurück zum Zitat Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, Angus DC (2008) Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 52(1):48–58PubMed Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, Angus DC (2008) Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 52(1):48–58PubMed
84.
Zurück zum Zitat Menéndez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos MA, Filella X, Niederman M, Torres A (2008) Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 63(5):447–452PubMed Menéndez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos MA, Filella X, Niederman M, Torres A (2008) Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 63(5):447–452PubMed
85.
Zurück zum Zitat Menéndez R, Martínez R, Reyes S, Mensa J, Filella X, Marcos MA, Martínez A, Esquinas C, Ramirez P, Torres A (2009) Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 64(7):587–591PubMed Menéndez R, Martínez R, Reyes S, Mensa J, Filella X, Marcos MA, Martínez A, Esquinas C, Ramirez P, Torres A (2009) Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 64(7):587–591PubMed
86.
Zurück zum Zitat Huang DT, Angus DC, Kellum JA, Pugh NA, Weissfeld LA, Struck J, Delude RL, Rosengart MR, Yealy DM (2009) Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest 136(3):823–831PubMed Huang DT, Angus DC, Kellum JA, Pugh NA, Weissfeld LA, Struck J, Delude RL, Rosengart MR, Yealy DM (2009) Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest 136(3):823–831PubMed
87.
Zurück zum Zitat Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T; German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group (2010) Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 182(11):1426–1434PubMed Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T; German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group (2010) Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 182(11):1426–1434PubMed
88.
Zurück zum Zitat Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T; CAPNETZ Study Group (2010) Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ. Thorax 65(3):208–214PubMed Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T; CAPNETZ Study Group (2010) Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ. Thorax 65(3):208–214PubMed
89.
Zurück zum Zitat Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, Graff LG, Fine JM, Fine MJ (2005) Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118(4):384–392PubMed Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, Graff LG, Fine JM, Fine MJ (2005) Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118(4):384–392PubMed
90.
Zurück zum Zitat Renaud B, Coma E, Labarere J, Hayon J, Roy PM, Boureaux H, Moritz F, Cibien JF, Guérin T, Carré E, Lafontaine A, Bertrand MP, Santin A, Brun-Buisson C, Fine MJ, Roupie E (2007) Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clin Infect Dis 44(1):41–49PubMed Renaud B, Coma E, Labarere J, Hayon J, Roy PM, Boureaux H, Moritz F, Cibien JF, Guérin T, Carré E, Lafontaine A, Bertrand MP, Santin A, Brun-Buisson C, Fine MJ, Roupie E (2007) Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clin Infect Dis 44(1):41–49PubMed
91.
Zurück zum Zitat Valencia M, Badia JR, Cavalcanti M, Ferrer M, Agustí C, Angrill J, García E, Mensa J, Niederman MS, Torres A (2007) Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 132(2):515–522PubMed Valencia M, Badia JR, Cavalcanti M, Ferrer M, Agustí C, Angrill J, García E, Mensa J, Niederman MS, Torres A (2007) Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 132(2):515–522PubMed
92.
Zurück zum Zitat Ananda-Rajah MR, Charles PG, Melvani S, Burrell LL, Johnson PD, Grayson ML (2008) Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia. Scand J Infect Dis 40(4):293–300PubMed Ananda-Rajah MR, Charles PG, Melvani S, Burrell LL, Johnson PD, Grayson ML (2008) Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia. Scand J Infect Dis 40(4):293–300PubMed
93.
Zurück zum Zitat Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, Brown GV (2006) A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 61(5):419–424PubMed Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, Brown GV (2006) A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 61(5):419–424PubMed
94.
Zurück zum Zitat Aspa J, Rajas O, de Castro FR (2008) Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother 9(2):229–241PubMed Aspa J, Rajas O, de Castro FR (2008) Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother 9(2):229–241PubMed
95.
Zurück zum Zitat Lynch JP 3rd, Zhanel GG (2005) Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy. Semin Respir Crit Care Med 26(6):575–616PubMed Lynch JP 3rd, Zhanel GG (2005) Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy. Semin Respir Crit Care Med 26(6):575–616PubMed
96.
Zurück zum Zitat Campbell GD Jr, Silberman R (1998) Drug-resistant Streptococcus pneumoniae. Clin Infect Dis 26(5):1188–1195PubMed Campbell GD Jr, Silberman R (1998) Drug-resistant Streptococcus pneumoniae. Clin Infect Dis 26(5):1188–1195PubMed
97.
Zurück zum Zitat Clavo-Sánchez AJ, Girón-González JA, López-Prieto D, Canueto-Quintero J, Sánchez-Porto A, Vergara-Campos A, Marín-Casanova P, Córdoba-Doña JA (1997) Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 24(6):1052–1059PubMed Clavo-Sánchez AJ, Girón-González JA, López-Prieto D, Canueto-Quintero J, Sánchez-Porto A, Vergara-Campos A, Marín-Casanova P, Córdoba-Doña JA (1997) Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 24(6):1052–1059PubMed
98.
Zurück zum Zitat Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A (2005) Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 40(9):1288–1297PubMed Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A (2005) Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 40(9):1288–1297PubMed
99.
Zurück zum Zitat Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MB, Andremont A, Klugman KP (2003) An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 37(2):230–237PubMed Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MB, Andremont A, Klugman KP (2003) An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 37(2):230–237PubMed
100.
Zurück zum Zitat File TM Jr (2006) Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia. Clin Microbiol Infect 12(Suppl 3):31–41PubMed File TM Jr (2006) Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia. Clin Microbiol Infect 12(Suppl 3):31–41PubMed
101.
Zurück zum Zitat Bradley SF (2005) Staphylococcus aureus pneumonia: emergence of MRSA in the community. Semin Respir Crit Care Med 26(6):643–649PubMed Bradley SF (2005) Staphylococcus aureus pneumonia: emergence of MRSA in the community. Semin Respir Crit Care Med 26(6):643–649PubMed
102.
Zurück zum Zitat Drews TD, Temte JL, Fox BC (2006) Community-associated methicillin-resistant Staphylococcus aureus: review of an emerging public health concern. WMJ 105(1):52–57PubMed Drews TD, Temte JL, Fox BC (2006) Community-associated methicillin-resistant Staphylococcus aureus: review of an emerging public health concern. WMJ 105(1):52–57PubMed
103.
Zurück zum Zitat Ebert MD, Sheth S, Fishman EK (2009) Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of “mayhem in the lung”. Emerg Radiol 16:159–162PubMed Ebert MD, Sheth S, Fishman EK (2009) Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of “mayhem in the lung”. Emerg Radiol 16:159–162PubMed
104.
Zurück zum Zitat Prevost G, Couppie P, Prevost P, Gayet S, Petiau P, Cribier B, Monteil H, Piemont Y (1995) Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 42(4):237–245PubMed Prevost G, Couppie P, Prevost P, Gayet S, Petiau P, Cribier B, Monteil H, Piemont Y (1995) Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 42(4):237–245PubMed
105.
Zurück zum Zitat Nimmo GR, Coombs GW (2008) Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents 31(5):401–410PubMed Nimmo GR, Coombs GW (2008) Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents 31(5):401–410PubMed
106.
Zurück zum Zitat Roberts JC, Gulino SP, Peak KK, Luna VA, Sanderson R (2008) Fatal necrotizing pneumonia due to a Panton–Valentine leukocidin positive community-associated methicillin-sensitive Staphylococcus aureus and Influenza co-infection: a case report. Ann Clin Microbiol Antimicrob 7:5PubMed Roberts JC, Gulino SP, Peak KK, Luna VA, Sanderson R (2008) Fatal necrotizing pneumonia due to a Panton–Valentine leukocidin positive community-associated methicillin-sensitive Staphylococcus aureus and Influenza co-infection: a case report. Ann Clin Microbiol Antimicrob 7:5PubMed
107.
Zurück zum Zitat Rougemont AL, Buteau C, Ovetchkine P, Bergeron C, Fournet JC, Bouron-Dal Soglio D (2009) Fatal cases of Staphylococcus aureus pleural empyema in infants. Pediatr Dev Pathol 12(5):390–393PubMed Rougemont AL, Buteau C, Ovetchkine P, Bergeron C, Fournet JC, Bouron-Dal Soglio D (2009) Fatal cases of Staphylococcus aureus pleural empyema in infants. Pediatr Dev Pathol 12(5):390–393PubMed
108.
Zurück zum Zitat Arancibia F, Bauer TT, Ewig S, Mensa J, Gonzalez J, Niederman MS, Torres A (2002) Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 162(16):1849–1858PubMed Arancibia F, Bauer TT, Ewig S, Mensa J, Gonzalez J, Niederman MS, Torres A (2002) Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 162(16):1849–1858PubMed
109.
Zurück zum Zitat Garau J, Gomez L (2003) Pseudomonas aeruginosa pneumonia. Curr Opin Infect Dis 16(2):135–143PubMed Garau J, Gomez L (2003) Pseudomonas aeruginosa pneumonia. Curr Opin Infect Dis 16(2):135–143PubMed
110.
Zurück zum Zitat Lim I, Shaw DR, Stanley DP, Lumb R, McLennan G (1989) A prospective hospital study of the aetiology of community-acquired pneumonia. Med J Aust 151(2):87–91PubMed Lim I, Shaw DR, Stanley DP, Lumb R, McLennan G (1989) A prospective hospital study of the aetiology of community-acquired pneumonia. Med J Aust 151(2):87–91PubMed
111.
Zurück zum Zitat Venkatesan P, Gladman J, Macfarlane JT, Barer D, Berman P, Kinnear W, Finch RG (1990) A hospital study of community acquired pneumonia in the elderly. Thorax 45(4):254–258PubMed Venkatesan P, Gladman J, Macfarlane JT, Barer D, Berman P, Kinnear W, Finch RG (1990) A hospital study of community acquired pneumonia in the elderly. Thorax 45(4):254–258PubMed
112.
Zurück zum Zitat Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR, Yee UC, Rihs JD, Vickers R (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 69(5):307–316 Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR, Yee UC, Rihs JD, Vickers R (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 69(5):307–316
113.
Zurück zum Zitat Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, Torres A (1999) Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 160(2):397–405PubMed Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, Torres A (1999) Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 160(2):397–405PubMed
114.
Zurück zum Zitat Liam CK, Lim KH, Wong CM (2001) Community-acquired pneumonia in patients requiring hospitalization. Respirology 6(3):259–264PubMed Liam CK, Lim KH, Wong CM (2001) Community-acquired pneumonia in patients requiring hospitalization. Respirology 6(3):259–264PubMed
115.
Zurück zum Zitat Tan YK, Khoo KL, Chin SP, Ong YY (1998) Aetiology and outcome of severe community-acquired pneumonia in Singapore. Eur Respir J 12(1):113–115PubMed Tan YK, Khoo KL, Chin SP, Ong YY (1998) Aetiology and outcome of severe community-acquired pneumonia in Singapore. Eur Respir J 12(1):113–115PubMed
116.
Zurück zum Zitat Marik PE (2000) The clinical features of severe community-acquired pneumonia presenting as septic shock. Norasept II Study Investigators. J Crit Care 15(3):85–90PubMed Marik PE (2000) The clinical features of severe community-acquired pneumonia presenting as septic shock. Norasept II Study Investigators. J Crit Care 15(3):85–90PubMed
117.
Zurück zum Zitat von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, Lück C (2008) Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis 46(9):1356–1364 von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, Lück C (2008) Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis 46(9):1356–1364
118.
Zurück zum Zitat Sopena N, Force L, Pedro-Botet ML, Barrufet P, Sauca G, García-Núñez M, Tolchinsky G, Capdevila JA, Sabrià M (2007) Sporadic and epidemic community legionellosis: two faces of the same illness. Eur Respir J 29(1):138–142PubMed Sopena N, Force L, Pedro-Botet ML, Barrufet P, Sauca G, García-Núñez M, Tolchinsky G, Capdevila JA, Sabrià M (2007) Sporadic and epidemic community legionellosis: two faces of the same illness. Eur Respir J 29(1):138–142PubMed
119.
Zurück zum Zitat Luna CM, Brea Folco J, Aruj P, Rebora K, Balsebre C, Absi R, Vay C, De Mier C, Famiglietti A (2004) Pneumonia due to Legionella pneumophila. Experience gathered in a University Hospital in Buenos Aires. Medicina (B Aires) 64(2):97–102 Luna CM, Brea Folco J, Aruj P, Rebora K, Balsebre C, Absi R, Vay C, De Mier C, Famiglietti A (2004) Pneumonia due to Legionella pneumophila. Experience gathered in a University Hospital in Buenos Aires. Medicina (B Aires) 64(2):97–102
120.
Zurück zum Zitat Sopena N, Pedro-Botet L, Mateu L, Tolschinsky G, Rey-Joly C, Sabrià M (2007) Community-acquired legionella pneumonia in elderly patients: characteristics and outcome. J Am Geriatr Soc 55(1):114–119PubMed Sopena N, Pedro-Botet L, Mateu L, Tolschinsky G, Rey-Joly C, Sabrià M (2007) Community-acquired legionella pneumonia in elderly patients: characteristics and outcome. J Am Geriatr Soc 55(1):114–119PubMed
121.
Zurück zum Zitat Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Verheij TJ (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26(6):1138–1180PubMed Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Verheij TJ (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26(6):1138–1180PubMed
122.
Zurück zum Zitat Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC (2008) Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study—a randomized clinical trial. Clin Infect Dis 46(10):1499–1509PubMed Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC (2008) Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study—a randomized clinical trial. Clin Infect Dis 46(10):1499–1509PubMed
Metadaten
Titel
Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality
verfasst von
T. Welte
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 1/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1272-4

Weitere Artikel der Ausgabe 1/2012

European Journal of Clinical Microbiology & Infectious Diseases 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.